Search Results - "Dashti, Sepideh"

Refine Results
  1. 1

    An in-silico method leads to recognition of hub genes and crucial pathways in survival of patients with breast cancer by Dashti, Sepideh, Taheri, Mohammad, Ghafouri-Fard, Soudeh

    Published in Scientific reports (30-10-2020)
    “…Breast cancer is a highly heterogeneous disorder characterized by dysregulation of expression of numerous genes and cascades. In the current study, we aim to…”
    Get full text
    Journal Article
  2. 2

    The role of long non-coding RNA CASC2 in the carcinogenesis process by Ghafouri-Fard, Soudeh, Dashti, Sepideh, Taheri, Mohammad

    Published in Biomedicine & pharmacotherapy (01-07-2020)
    “…The lncRNA cancer susceptibility candidate 2 (CASC2) has been initially discovered in a genomic area on 10q26 that is commonly lost in human endometrial…”
    Get full text
    Journal Article
  3. 3

    A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies by Ghafouri-Fard, Soudeh, Dashti, Sepideh, Farsi, Molood, Hussen, Bashdar Mahmud, Taheri, Mohammad

    Published in Biomedicine & pharmacotherapy (01-05-2021)
    “…OIP5-AS1 is a long non-coding transcript with high expression in nervous system, but crucial functions in the neoplastic transformation. This lncRNA partake in…”
    Get full text
    Journal Article
  4. 4

    The HOTTIP (HOXA transcript at the distal tip) lncRNA: Review of oncogenic roles in human by Ghafouri-Fard, Soudeh, Dashti, Sepideh, Taheri, Mohammad

    Published in Biomedicine & pharmacotherapy (01-07-2020)
    “…HOXA transcript at the distal tip (HOTTIP) is a 3764 nucleotide long non-coding RNA (lncRNA) encoded from a genomic region in the 5′ tip of the HOXA locus…”
    Get full text
    Journal Article
  5. 5

    Deleted in lymphocytic leukemia 2 (DLEU2): An lncRNA with dissimilar roles in different cancers by Ghafouri-Fard, Soudeh, Dashti, Sepideh, Farsi, Molood, Taheri, Mohammad

    Published in Biomedicine & pharmacotherapy (01-01-2021)
    “…Deleted in lymphocytic leukemia 2" (DLEU2) is a long non-coding transcript with several splice variants. It has been identified through a comprehensive…”
    Get full text
    Journal Article
  6. 6

    In silico identification of MAPK14-related lncRNAs and assessment of their expression in breast cancer samples by Dashti, Sepideh, Taherian-Esfahani, Zahra, Kholghi-Oskooei, Vahid, Noroozi, Rezvan, Arsang-Jang, Sharam, Ghafouri-Fard, Soudeh, Taheri, Mohammad

    Published in Scientific reports (20-05-2020)
    “…Mitogen-activated protein kinase (MAP kinase) pathways participate in regulation of several cellular processes involved in breast carcinogenesis. A number of…”
    Get full text
    Journal Article
  7. 7

    Associations between XRCC3 Thr241Met polymorphisms and breast cancer risk: systematic-review and meta-analysis of 55 case-control studies by Dashti, Sepideh, Taherian-Esfahani, Zahra, Keshtkar, Abbasali, Ghafouri-Fard, Soudeh

    Published in BMC medical genetics (10-05-2019)
    “…The X-ray repair cross-complementing group 3 (XRCC3) is an efficient component of homologous recombination and is required for the preservation of chromosomal…”
    Get full text
    Journal Article
  8. 8

    TINCR: An lncRNA with dual functions in the carcinogenesis process by Ghafouri-Fard, Soudeh, Dashti, Sepideh, Taheri, Mohammad, Omrani, Mir Davood

    Published in Non-coding RNA research (01-09-2020)
    “…Long non-coding RNAs (lncRNAs) have prominent roles in the pathogenesis of human cancers. Several studies have shown oncogenic or tumor suppressor roles of…”
    Get full text
    Journal Article
  9. 9

    Prevalence of high‐risk human papillomavirus infection in women with ovarian endometriosis by Heidarpour, Mitra, Derakhshan, Maryam, Derakhshan‐Horeh, Marzieh, Kheirollahi, Majid, Dashti, Sepideh

    “…Aim In this study, we aimed to determine the prevalence of human papillomavirus (HPV) in ovarian endometriosis and ovarian tissue from women without…”
    Get full text
    Journal Article
  10. 10

    X-Inactive-Specific Transcript: Review of Its Functions in the Carcinogenesis by Ghafouri-Fard, Soudeh, Dashti, Sepideh, Farsi, Molood, Taheri, Mohammad, Mousavinejad, Seyed Ali

    “…X-inactive–specific transcript (XIST) is one of the firstly discovered long non-coding RNAs with prominent roles in the process of X inactivation. Moreover,…”
    Get full text
    Journal Article
  11. 11

    The Contingent Body by Dashti, Sepideh Tajalizadeh

    Published in Contemporaneity (Pittsburgh, PA) (21-02-2021)
    “…The Contingent Body  …”
    Get full text
    Journal Article
  12. 12

    Brain tumors: Special characters for research and banking by Kheirollahi, Majid, Dashti, Sepideh, Khalaj, Zahra, Nazemroaia, Fatemeh, Mahzouni, Parvin

    Published in Advanced biomedical research (2015)
    “…A brain tumor is an intracranial neoplasm within the brain or in the central spinal canal. Primary malignant brain tumors affect about 200,000 people worldwide…”
    Get full text
    Journal Article
  13. 13

    PCAT1: An oncogenic lncRNA in diverse cancers and a putative therapeutic target by Ghafouri-Fard, Soudeh, Dashti, Sepideh, Taheri, Mohammad

    Published in Experimental and molecular pathology (01-06-2020)
    “…The critical roles of long non-coding RNAs (lncRNAs) in the regulation of diverse biological functions has potentiated them as cancer biomarkers. Among these…”
    Get full text
    Journal Article
  14. 14

    HOX transcript antisense RNA: An oncogenic lncRNA in diverse malignancies by Ghafouri-Fard, Soudeh, Dashti, Sepideh, Farsi, Molood, Taheri, Mohammad

    Published in Experimental and molecular pathology (01-02-2021)
    “…HOX transcript antisense RNA (HOTAIR) is a transcript produced from the antisense strand of the HOXC gene cluster and influencing expression of genes from the…”
    Get full text
    Journal Article
  15. 15

    Expression profile of lncRNAs and miRNAs in esophageal cancer: Implications in diagnosis, prognosis, and therapeutic response by Ghafouri‐Fard, Soudeh, Shoorei, Hamed, Dashti, Sepideh, Branicki, Wojciech, Taheri, Mohammad

    Published in Journal of cellular physiology (01-12-2020)
    “…Esophageal cancer is the seventh most common cancer worldwide. Although a number of environmental and lifestyle‐related risk factors have been identified for…”
    Get full text
    Journal Article
  16. 16

    Expression analysis of vimentin and the related lncRNA network in breast cancer by Mohebi, Mehdi, Ghafouri-Fard, Soudeh, Modarressi, Mohammad Hossein, Dashti, Sepideh, Zekri, Ali, Kholghi-Oskooei, Vahid, Taheri, Mohammad

    Published in Experimental and molecular pathology (01-08-2020)
    “…Vimentin (VIM) is a mesenchymal marker which is expressed in some cancer types including breast cancer. A long non-coding RNA (lncRNA) has been identified to…”
    Get full text
    Journal Article
  17. 17

    BCYRN1: An oncogenic lncRNA in diverse cancers by Ghafouri-Fard, Soudeh, Dashti, Sepideh, Hussen, Bashdar Mahmud, Farsi, Molood, Taheri, Mohammad

    Published in Pathology, research and practice (01-04-2021)
    “…Brain cytoplasmic 200 (BC200) or alternatively named as brain cytoplasmic RNA 1 (BCYRN1) is a long non-coding RNA (lncRNA) primarily identified in the neurons…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer by Dashti, Sepideh, Ghafouri-Fard, Soudeh, Esfandi, Farbod, Oskooei, Vahid Kholghi, Arsang-Jang, Shahram, Taheri, Mohammad

    Published in Experimental and molecular pathology (01-02-2020)
    “…The nuclear factor-κB (NF-κB) has a prominent role in development of breast cancer and response of patients to conventional therapies. Several factors regulate…”
    Get full text
    Journal Article
  20. 20

    Assessment of the expression pattern of mTOR‐associated lncRNAs and their genomic variants in the patients with breast cancer by Taherian‐Esfahani, Zahra, Taheri, Mohammad, Dashti, Sepideh, Kholghi‐Oskooei, Vahid, Geranpayeh, Lobat, Ghafouri‐Fard, Soudeh

    Published in Journal of cellular physiology (01-12-2019)
    “…The mechanistic target of rapamycin (mTOR) is a fundamental component of a signaling pathway that is involved in the pathogenesis of breast cancer via…”
    Get full text
    Journal Article